861 related articles for article (PubMed ID: 26011029)
1. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
[TBL] [Abstract][Full Text] [Related]
2. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
[TBL] [Abstract][Full Text] [Related]
3. Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL-2 Study): study protocol for a randomised controlled trial.
Taheri S; Asim M; Al Malki H; Fituri O; Suthanthiran M; August P;
Trials; 2018 Apr; 19(1):230. PubMed ID: 29665833
[TBL] [Abstract][Full Text] [Related]
4. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study.
Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G;
J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588
[TBL] [Abstract][Full Text] [Related]
5. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
[TBL] [Abstract][Full Text] [Related]
6. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
Liu JJ; Pek SLT; Ang K; Tavintharan S; Lim SC;
J Clin Endocrinol Metab; 2017 Oct; 102(10):3683-3691. PubMed ID: 28973352
[TBL] [Abstract][Full Text] [Related]
7. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
[TBL] [Abstract][Full Text] [Related]
9. Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes.
Schievink B; Kröpelin T; Mulder S; Parving HH; Remuzzi G; Dwyer J; Vemer P; de Zeeuw D; Lambers Heerspink HJ
Diabetes Obes Metab; 2016 Jan; 18(1):64-71. PubMed ID: 26434564
[TBL] [Abstract][Full Text] [Related]
10. Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D).
Fried LF; Duckworth W; Zhang JH; O'Connor T; Brophy M; Emanuele N; Huang GD; McCullough PA; Palevsky PM; Seliger S; Warren SR; Peduzzi P;
Clin J Am Soc Nephrol; 2009 Feb; 4(2):361-8. PubMed ID: 19118120
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of chronic kidney disease and associated factors in Chinese individuals with type 2 diabetes: Cross-sectional study.
Guo K; Zhang L; Zhao F; Lu J; Pan P; Yu H; Bao Y; Chen H; Jia W
J Diabetes Complications; 2016 Jul; 30(5):803-10. PubMed ID: 27068269
[TBL] [Abstract][Full Text] [Related]
12. Design of a phase 2 clinical trial of an ASK1 inhibitor, GS-4997, in patients with diabetic kidney disease.
Lin JH; Zhang JJ; Lin SL; Chertow GM
Nephron; 2015; 129(1):29-33. PubMed ID: 25531162
[TBL] [Abstract][Full Text] [Related]
13. Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study.
Farah RI; Al-Sabbagh MQ; Momani MS; Albtoosh A; Arabiat M; Abdulraheem AM; Aljabiri H; Abufaraj M
BMC Nephrol; 2021 Jun; 22(1):223. PubMed ID: 34134654
[TBL] [Abstract][Full Text] [Related]
14. Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort.
Hellemons ME; Denig P; de Zeeuw D; Voorham J; Lambers Heerspink HJ
Nephrol Dial Transplant; 2013 Mar; 28(3):706-15. PubMed ID: 23262433
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
[TBL] [Abstract][Full Text] [Related]
16. The unrecognized prevalence of chronic kidney disease in diabetes.
Middleton RJ; Foley RN; Hegarty J; Cheung CM; McElduff P; Gibson JM; Kalra PA; O'Donoghue DJ; New JP
Nephrol Dial Transplant; 2006 Jan; 21(1):88-92. PubMed ID: 16221715
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of normoalbuminuria and renal impairment in type 2 diabetes mellitus
.
Pichaiwong W; Homsuwan W; Leelahavanichkul A
Clin Nephrol; 2019 Aug; 92(2):73-80. PubMed ID: 31198168
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.
Robles NR; Romero B; Fernandez-Carbonero E; Sánchez-Casado E; Cubero JJ
J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):195-200. PubMed ID: 20026868
[TBL] [Abstract][Full Text] [Related]
19. Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
Afkarian M; Zelnick LR; Ruzinski J; Kestenbaum B; Himmelfarb J; de Boer IH; Mehrotra R
J Diabetes Complications; 2015; 29(8):1024-31. PubMed ID: 26412030
[TBL] [Abstract][Full Text] [Related]
20. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
